Skip to content

Dr. DANVOYE Leslie

Active
Private limited companyfounded 2010active for 16 yearsChemin de la Cure d'Air 29, 7021 Mons, BelgiumKBO/BCE: BE 0830.592.885

From the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. DANVOYE Leslie has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €51,255 and a net result of €8,777. Equity is growing by about 11% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 12-10-2010 Normal situation
Legal form
Private limited company
Registered office
Chemin de la Cure d'Air 29, 7021 Mons
Activity
No activity registered in the KBO
Establishment unit
2.193.903.834 7021 Mons, since 25-10-2010
Financial year end
31 December
Peppol
Reachable since 17-11-2025

Who decides

Board

How it is doing

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€11,456
▼ 29.3%
Turnover
≈ €88,000
estimated
Profit
€8,777
▼ 12.5%
Equity
€51,255
▲ 20.7%
Total assets
€51,936
▲ 18.8%
2025 accounts 42 days early
Filed on 19-06-2026at the National Bank
Why 97raises riskNo main activity registeredlowers riskLiquidity: current ratio 74.85, cash €27,649Founded in 2010Size: total assets €51,936Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 81% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 98.7% of total assets
Liquidity 100+13
short-term debt 1.3% · cash 53.2%
Profitability 90-7
return on assets 16.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025highest value 07-2025: 0.2%▼ -0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.3%▲ +0.1 percentage points vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.2 percentage points vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €4,500 on 30-day terms is acceptable
Liquidity ample (current ratio 74.85, compared with 33.72 in 2024, above the usual 1.5; short-term debt: 1.3% and cash: 53.2% of total assets), and 1.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 95% on liquidity, 72% on profitability and 77% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 74.85, cash €27,649
NBB · annual accounts
raises risk · No main activity registered
KBO
lowers risk · Founded in 2010
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €51,936
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
42 days early
2024
46 days early
2023
47 days early
2022
41 days early
2021
41 days early
2020
33 days early
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 37 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Documents

Annual accounts at the NBB

All 15 annual accounts

Articles and registers

Key facts about Dr. DANVOYE Leslie

What is the company number of Dr. DANVOYE Leslie?
0830.592.885. In Belgium the VAT number is the company number with BE in front: BE 0830.592.885.
Where is Dr. DANVOYE Leslie based?
The registered office is at Chemin de la Cure d'Air 29, 7021 Mons.Company details
What is the legal form of Dr. DANVOYE Leslie?
Private limited company (BV).
When was Dr. DANVOYE Leslie founded?
On 12-10-2010.
Is Dr. DANVOYE Leslie still active?
Yes, Dr. DANVOYE Leslie is an active enterprise in the KBO register.
What is the turnover of Dr. DANVOYE Leslie?
≈ €88,000 in financial year 2025. Estimated from the gross margin of €11,456: probably between €40,000 and €210,000, based on 6,331 comparable companies of the same size. A rough estimate.Financials
Is Dr. DANVOYE Leslie profitable?
In financial year 2025, Dr. DANVOYE Leslie made a profit of €8,777.
Where can I find the annual accounts of Dr. DANVOYE Leslie?
Dr. DANVOYE Leslie filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. DANVOYE Leslie due?
By 31-07-2027, for financial year 2026.Timeline

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.